Publications by authors named "Jan Andersen"

Claim this Profile
I
Impact of antibody Fc engineering on translational pharmacology, and safety: insights from industry case studies.
Frank R Brennan, J Ryan Polli, Jean Sathish, Melissa Ramones, Babette Wolf, Jan Terje Andersen

MAbs· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic benchmarking of mass spectrometry-based antibody sequencing reveals methodological biases.
Maria Chernigovskaya, Khang Lê Quý, Maria Stensland, Sachin Singh, Rowan Nelson, Jan Terje Andersen

Cell Syst· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tailored collagen binding of albumin-fused hyperactive coagulation factor IX dictates in vivo distribution and functional properties.
Kristin Hovden Aaen, Maria Francesca Testa, Jeannette Nilsen, Rebecca Tarantino, Cesare Canepari, Mari Nyquist-Andersen, Jan Terje Andersen

Nat Commun· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced microbiome therapeutics for oral delivery of peptides and proteins: Advances, challenges, and opportunities.
Hitesh P Gelli, Ruben Vazquez-Uribe, Stephen T Buckley, Jan Terje Andersen, Morten Otto Alexander Sommer

Adv Drug Deliv Rev· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploiting FcRn engagement of an albumin-CpG oligonucleotide covalent conjugate for potent TLR9 immune induction.
Diego Pilati, Eugene Kusi Agyei, Marwa Elkhashab, Elisabeth Fuchs, Ian Helstrup Nielsen, Jan Terje Andersen

J Biol Chem· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a direct interaction between the Fab domains of IgG antibodies and human FcRn upon IgG-FcRn complex formation.
Esben Trabjerg, Jeannette Nilsen, Torleif Tollefsrud Gjølberg, Jan Terje Andersen, Alexander Leitner

Commun Biol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the Neonatal Fc Receptor in Autoimmune Diseases: Pipeline and Progress.
Torleif Tollefsrud Gjølberg, Simone Mester, Gaia Calamera, Jenny Skjermo Telstad, Inger Sandlie, Jan Terje Andersen

BioDrugs· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Appendiceal Tumor Prevalence in Patients With Periappendicular Abscess.
Roosa Salminen, Jenny Alajääski, Tero Rautio, Saija Hurme, Pia Nordström

JAMA Surg· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An intranasal subunit vaccine induces protective systemic and mucosal antibody immunity against respiratory viruses in mouse models.
Aina Karen Anthi, Anette Kolderup, Eline Benno Vaage, Malin Bern, Sopisa Benjakul, Mari Nyquist-Andersen, Jan Terje Andersen

Nat Commun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced plasma half-life and efficacy of engineered human albumin-fused GLP-1 despite enzymatic cleavage of its C-terminal end.
Jeannette Nilsen, Kristin Hovden Aaen, Sopisa Benjakul, Fulgencio Ruso-Julve, Thomas Uwe Greiner, Jan Terje Andersen

Commun Biol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering of anticancer human immunoglobulin A equipped with albumin for enhanced plasma half-life.
Simone Mester, Chilam Chan, Marta Lustig, Stian Foss, J H Marco Jansen, Jan Terje Andersen

PNAS Nexus· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sialylation inhibition improves macrophage mediated tumor cell phagocytosis of breast cancer cells triggered by therapeutic antibodies of different isotypes.
Marta Lustig, Christoph Hahn, Marie Leangen Herigstad, Jan Terje Andersen, Jeanette H W Leusen

Front Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering of pH-dependent antigen binding properties for toxin-targeting IgG1 antibodies using light-chain shuffling.
Tulika Tulika, Fulgencio Ruso-Julve, Shirin Ahmadi, Anne Ljungars, Esperanza Rivera-de-Torre, Jan Terje Andersen

Structure· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biophysical cartography of the native and human-engineered antibody landscapes quantifies the plasticity of antibody developability.
Habib Bashour, Eva Smorodina, Matteo Pariset, Jahn Zhong, Rahmad Akbar, Jan Terje Andersen

Commun Biol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insight into the avidity-affinity relationship of the bivalent, pH-dependent interaction between IgG and FcRn.
Johannes Reusch, Jan Terje Andersen, Ulrich Rant, Tilman Schlothauer

MAbs· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteria.
Stian Foss, Siri A Sakya, Leire Aguinagalde, Marta Lustig, Jutamas Shaughnessy, Jan Terje Andersen

Nat Commun· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phage display assisted discovery of a pH-dependent anti-α-cobratoxin antibody from a natural variable domain library.
Tulika Tulika, Rasmus W Pedersen, Charlotte Rimbault, Shirin Ahmadi, Esperanza Rivera-de-Torre, Jan Terje Andersen

Protein Sci· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pan-SARS-CoV-2-specific soluble angiotensin-converting enzyme 2-albumin fusion engineered for enhanced plasma half-life and needle-free mucosal delivery.
Sopisa Benjakul, Aina Karen Anthi, Anette Kolderup, Marina Vaysburd, Heidrun Elisabeth Lode, Mari Nyquist-Andersen, Jan Terje Andersen

PNAS Nexus· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmaceutical compounding and storage of faricimab in a syringe for intravitreal injection do not impair stability and bi-specific binding properties.
Øystein Kalsnes Jørstad, Stian Foss, Torleif Tollefsrud Gjølberg, Simone Mester, Mari Nyquist-Andersen, Jan Terje Andersen

Int J Retina Vitreous· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disruption of the sialic acid/Siglec-9 axis improves antibody-mediated neutrophil cytotoxicity towards tumor cells.
Marta Lustig, Chilam Chan, J H Marco Jansen, Maria Bräutigam, Max A Kölling, Jan Terje Andersen

Front Immunol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody blockade of Jagged1 attenuates choroidal neovascularization.
Torleif Tollefsrud Gjølberg, Jonas Aakre Wik, Hanna Johannessen, Stig Krüger, Nicola Bassi, Jan Terje Andersen

Nat Commun· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytosolic antibody receptor TRIM21 is required for effective tau immunotherapy in mouse models.
Aamir S Mukadam, Lauren V C Miller, Annabel E Smith, Marina Vaysburd, Siri A Sakya, Jan Terje Andersen

Science· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing developability early in the discovery process for novel biologics.
Monica L Fernández-Quintero, Anne Ljungars, Franz Waibl, Victor Greiff, Jan Terje Andersen

MAbs· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity.
Arne Søraas, Gunnveig Grødeland, Beathe Kiland Granerud, Thor Ueland, Andreas Lind, Jan Terje Andersen

Front Immunol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biophysical differences in IgG1 Fc-based therapeutics relate to their cellular handling, interaction with FcRn and plasma half-life.
Torleif Tollefsrud Gjølberg, Rahel Frick, Simone Mester, Stian Foss, Algirdas Grevys, Jan Terje Andersen

Commun Biol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis